Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 6, Pages 1738
Publisher
MDPI AG
Online
2020-06-05
DOI
10.3390/jcm9061738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
- (2019) Raphaëla Carmen Dresen et al. CANCER IMAGING
- Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
- (2019) Koen P. Rovers et al. BMC CANCER
- A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
- (2019) Hideaki Bando et al. BRITISH JOURNAL OF CANCER
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer
- (2019) Erik J. van Helden et al. Molecular Oncology
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2018) Wijntje J. van Eden et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival
- (2018) Joel M. Baumgartner et al. ANNALS OF SURGICAL ONCOLOGY
- Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
- (2018) Nina R. Sluiter et al. ANNALS OF SURGICAL ONCOLOGY
- Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE)
- (2018) G. Passot et al. BRITISH JOURNAL OF SURGERY
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- (2018) Jeanne Tie et al. GUT
- A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
- (2018) François Quenet et al. JOURNAL OF CLINICAL ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
- (2018) Christina Demuth et al. Translational Oncology
- Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience
- (2018) Yael Feferman et al. ANNALS OF SURGICAL ONCOLOGY
- Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery
- (2018) I. van 't Sant et al. BRITISH JOURNAL OF SURGERY
- Establishing PNB-qPCR for quantifying minimal ctDNA concentrations during tumour resection
- (2017) T. Ehlert et al. Scientific Reports
- Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
- (2017) Oliver S. Eng et al. JAMA Surgery
- Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
- (2016) Rebecca M. Dodson et al. ANNALS OF SURGICAL ONCOLOGY
- Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial
- (2016) P.H. Cashin et al. EUROPEAN JOURNAL OF CANCER
- Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
- (2016) Jan Franko et al. LANCET ONCOLOGY
- Sequencing Structural Variants in Cancer for Precision Therapeutics
- (2016) Geoff Macintyre et al. TRENDS IN GENETICS
- Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel
- (2016) Kei A. Sato et al. PLoS One
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Metastatic pattern in colorectal cancer is strongly influenced by histological subtype
- (2014) N. Hugen et al. ANNALS OF ONCOLOGY
- Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
- (2014) R Mirnezami et al. BRITISH JOURNAL OF CANCER
- Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
- (2014) Hidde J. Braam et al. JOURNAL OF SURGICAL ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology
- (2014) Daoud Sie et al. CELLULAR ONCOLOGY
- Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
- (2013) Anke M. J. Kuijpers et al. ANNALS OF SURGICAL ONCOLOGY
- Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases
- (2013) D. Elias et al. EUROPEAN JOURNAL OF CANCER
- Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases
- (2012) E.M.V. de Cuba et al. CANCER TREATMENT REVIEWS
- Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis
- (2010) Jan Franko et al. CANCER
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
- (2009) Dominique Elias et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis
- (2008) Ju-Li Koh et al. ANNALS OF SURGICAL ONCOLOGY
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
- (2008) Vic J. Verwaal et al. ANNALS OF SURGICAL ONCOLOGY
- Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment
- (2008) Wim P Ceelen et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now